These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25120007)

  • 1. Structural Comparative Modeling of Multi-Domain F508del CFTR.
    McDonald EF; Woods H; Smith ST; Kim M; Schoeder CT; Plate L; Meiler J
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant.
    Borgo C; D'Amore C; Capurro V; Tomati V; Pedemonte N; Bosello Travain V; Salvi M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR.
    D'Amore C; Borgo C; Bosello Travain V; Salvi M
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.
    Farinha CM; Canato S
    Cell Mol Life Sci; 2017 Jan; 74(1):39-55. PubMed ID: 27699454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives.
    Brusa I; Sondo E; Falchi F; Pedemonte N; Roberti M; Cavalli A
    J Med Chem; 2022 Apr; 65(7):5212-5243. PubMed ID: 35377645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway.
    Im J; Hillenaar T; Yeoh HY; Sahasrabudhe P; Mijnders M; van Willigen M; Hagos A; de Mattos E; van der Sluijs P; Braakman I
    Cell Mol Life Sci; 2023 Jan; 80(1):33. PubMed ID: 36609925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of F508del CFTR unfolding and a search for stabilizing small molecules.
    Meng X; Ford RC
    Arch Biochem Biophys; 2024 Aug; 758():110050. PubMed ID: 38876247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation.
    Canato S; Santos JD; Carvalho AS; Aloria K; Amaral MD; Matthiesen R; Falcao AO; Farinha CM
    Cell Mol Life Sci; 2018 Dec; 75(24):4495-4509. PubMed ID: 30066085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transition.
    Quaresma MC; Botelho HM; Pankonien I; Rodrigues CS; Pinto MC; Costa PR; Duarte A; Amaral MD
    Life Sci Alliance; 2022 Sep; 5(9):. PubMed ID: 35500936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of hypoxia on the ion channels in cystic fibrosis bronchial epithelial cells].
    Pascarel K; Colas J; Mirval S; Becq F; Vandebrouck C
    Rev Mal Respir; 2023 Mar; 40(3):230-233. PubMed ID: 36775781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Plasticity Allows Calumenin-1 to Moonlight as a Ca
    Yadav MP; Narayanasamy S; Aradhyam GK
    Biochemistry; 2024 Jan; 63(1):69-81. PubMed ID: 38100476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability.
    Liu X; Dawson DC
    Biochemistry; 2014 Sep; 53(35):5613-8. PubMed ID: 25148434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic and bioinformatic analyses of possible target-related proteins of gambogic acid in human breast carcinoma MDA-MB-231 cells.
    Li D; Song XY; Yue QX; Cui YJ; Liu M; Feng LX; Wu WY; Jiang BH; Yang M; Qu XB; Liu X; Guo DA
    Chin J Nat Med; 2015 Jan; 13(1):41-51. PubMed ID: 25660287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small LEA proteins mitigate air-water interface damage to fragile cryo-EM samples during plunge freezing.
    Abe KM; Li G; He Q; Grant T; Lim CJ
    Nat Commun; 2024 Sep; 15(1):7705. PubMed ID: 39231985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers.
    Nasri Nasrabadi P; Nayeri Z; Gharib E; Salmanipour R; Masoomi F; Mahjoubi F; Zomorodipour A
    PLoS One; 2020; 15(5):e0233717. PubMed ID: 32469983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical characterisation of calumenin as a charged F508del-CFTR folding modulator.
    Tripathi R; Benz N; Culleton B; Trouvé P; Férec C
    PLoS One; 2014; 9(8):e104970. PubMed ID: 25120007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calumenin contributes to ER-Ca
    Philippe R; Antigny F; Buscaglia P; Norez C; Huguet F; Castelbou C; Trouvé P; Becq F; Frieden M; Férec C; Mignen O
    Cell Calcium; 2017 Mar; 62():47-59. PubMed ID: 28189267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
    Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
    ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.